"Imunorix" is an immunostimulating drug. Its active ingredient pidotimod is able to regulate and stimulate humoral and cellular immunity in conditions of immunodeficiency.
"Imunorix": indications for use, composition of the drug
The drug "Imunorix" is prescribed as part of a complex treatment for the purpose of immunocorrection in viral, bacterial, fungal infectious diseases of the lower and upper respiratory tract, as well as for immunocorrection in bacterial, viral, fungal infections of the urinary tract. When acting on T-cell immunity, the active substance pidotimod increases the activity of natural killer cells, and also activates phagocytosis. When acting on humoral immunity, the active substance of the drug increases the synthesis of cytokines (mediators involved in the formation of the body's defense reactions).
The drug "Imunorix" is available in the form of a solution for oral administration. The drug looks like a transparent liquid of red-violet color with the smell of wild berries. One bottle of "Imunorix" contains 400 mg of the drug. In addition to pidotimod, the preparation includes:
- sodium methyl parahydroxybenzoate (10.3 mg), - sodium chloride (5.6 mg), - trometamol (up to pH 6, 5), - sodium saccharinate (5.0 mg), - sodium propyl parahydroxybenzoate (1, 6 mg), - edetate disodium (3.5 mg), - anthocyanin (5, 6 mg), - crimson dye (0.5 mg), - fruit flavor (21.0 mg), - water (7, 0 ml), - sorbitol 70% (2500 mg).
"Imunorix" should be stored at a temperature not exceeding 30 ° C in a place inaccessible to children. The shelf life of the drug is 3 years.
Instructions for the use of "Imunorix", contraindications, reviews of the drug
Adults are usually prescribed 800 mg of the drug (2 bottles) twice a day. The remedy must be taken regardless of when there was a meal. The therapeutic course should last for 15 days. Children aged three years and older are given 400 milligrams of the drug (one bottle) twice a day, regardless of food intake. The course of therapy is 15 days. The duration of use and the dose of "Imunorix" are subject to correction depending on the expressed symptoms and the severity of the disease. The duration of treatment with "Imunorix" is no more than three months.
The maximum daily amount of the drug at the age of 3 years is 800 mg, for adults - 1600 mg.
According to reviews, "Imunorix" sometimes causes allergic reactions, it can affect the therapeutic effect of drugs that stimulate or suppress the functional action of lymphocytes. The drug is contraindicated in case of hypersensitivity to any component of the drug, in children under 3 years of age, during pregnancy, lactation (breastfeeding). With caution, Imunorix is prescribed to patients with hyperimmunoglobulinemia E syndrome, as well as with a history of allergic reactions (medical history).